Priothera Enters Loan Agreement of €17.5 Million with the European Investment Bank
/PRNewswire/ -- Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator drug, mocravimod, today...
Frazer Hall United States Christian Kettel Thomsen Simone Seiter Sylvie Berrebi Prnewswire Priothera
Source: prnewswire.com